Active Lungs & Breathing Infection & Immunity

Immune regulation of the hyaluronan matrix in the lung during infection, injury and repair

In plain English

AI plain-English summary

A single molecule called hyaluronan, a giant sugar that gives lung tissue its bounce and structure, is being reshaped by the immune system in ways that can either heal the lungs or drive them into disease. This matters because the same molecule that helps repair lung damage after a worm infection also thickens airways in asthma and worsens flu and COVID-19. Researchers know that the immune signal IL-13 triggers hyaluronan production, but they do not understand why the resulting matrix sometimes helps and sometimes harms. Without that knowledge, doctors cannot tell whether boosting or blocking hyaluronan formation is the right move for a given patient. This project will map the hyaluronan matrix in three distinct settings—viral infection, allergic airway remodelling, and repair after parasite migration—to see exactly how its composition and location differ. The team will then manipulate the matrix in mouse models to test whether changing it alters immune responses and disease outcomes. If successful, this work could reveal new targets for therapies that steer hyaluronan toward repair and away from pathology, potentially improving treatment for asthma, severe respiratory infections, and lung injury.

View original technical description
The extracellular matrix component hyaluronan (HA) is an enormous polysaccharide that dictates tissue elasticity, hydration and directs immune cell behaviour. During lung inflammation, HA content increases dramatically and it becomes modified by HA-binding proteins to form diverse HA matrix structures. While HA matrix formation is essential for effective tissue repair, it is a key component of the remodelled airway in asthma and a driver of disease severity in influenza and COVID-19. We recently discovered that the type 2 cytokine IL-13 induces HA in the lung during acute viral infection, chronic allergic airway remodelling and during repair following nematode migration. Critically, we do not fully understand the composition of the HA matrix in these distinct settings and how or when it helps resolve inflammation, repair damage or promote disease pathology. Using established disease models, we will study IL-13-mediated HA matrix formation and function with the aim to: 1) define the composition and spatially map the HA matrix in pathogenic vs protective contexts; 2) define the immune context that instructs HA matrix formation; 3) manipulate the HA matrix to address its impact on the immune response and disease outcome for therapeutic benefit. Keywords: Hyaluronan; extracellular-matrix; IL-13; macrophage; asthma; helminth infection; respiratory virus.

View the original record at the funder ↗

Researchers

Tara Elaine Sutherland (EPMC Awardee)William Petri (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Revealing complexity of hyaluronan-protein interactions: novel tools and insights
The role of leukotriene A4 hydrolase in dictating inflammation and remodelling in chronic lung diseases
Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
Epithelial-Alveolar Macrophage interactions underlying the regulation of allergic inflammation and remodelling .
Investigating the influence of immune cells and mediators on lung extracellular matrix remodelling during asthma.

Original classification

Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.